Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Total Current Liabilities (2021 - 2025)

Historic Total Current Liabilities for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to $152.0 million.

  • Roivant Sciences' Total Current Liabilities rose 740.72% to $152.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $152.0 million, marking a year-over-year increase of 740.72%. This contributed to the annual value of $149.4 million for FY2025, which is 4399.01% down from last year.
  • Roivant Sciences' Total Current Liabilities amounted to $152.0 million in Q4 2025, which was up 740.72% from $133.9 million recorded in Q3 2025.
  • Roivant Sciences' 5-year Total Current Liabilities high stood at $556.2 million for Q3 2024, and its period low was $113.9 million during Q2 2025.
  • Over the past 5 years, Roivant Sciences' median Total Current Liabilities value was $224.9 million (recorded in 2021), while the average stood at $231.9 million.
  • Per our database at Business Quant, Roivant Sciences' Total Current Liabilities skyrocketed by 10947.37% in 2024 and then plummeted by 7593.58% in 2025.
  • Over the past 5 years, Roivant Sciences' Total Current Liabilities (Quarter) stood at $160.7 million in 2021, then surged by 51.98% to $244.3 million in 2022, then grew by 0.26% to $244.9 million in 2023, then plummeted by 42.23% to $141.5 million in 2024, then grew by 7.41% to $152.0 million in 2025.
  • Its last three reported values are $152.0 million in Q4 2025, $133.9 million for Q3 2025, and $113.9 million during Q2 2025.